Skip to Main Content

Paper Details

Phenotype of GABA-transaminase deficiency.
Neurology
37
2017
-aminobutyric acid, -aminobutyric acid (GABA)-transaminase, -aminobutyric acid (GABA)-transaminase deficiency, GABA, GABA-A benzodiazepine receptor, GABA-transaminase, GABA-transaminase deficiency, accelerated, benzodiazepine, choreoathetosis, epilepsy, flumazenil, hypersomnolence, hypotonia, hypsarrhythmia, lethality, neonatal or early infantile-onset encephalopathy, neonatal or infantile-onset encephalopathy, patient, patients
Author NameAffiliation
Mary Kay KoenigUniversity of Texas Medical School, Boston Children's Hospital, Harvard Medical School, Columbia University School of Medicine, Kanagawa Children's Medical Center, Jichi Medical School, Washington State University, Baylor College of Medicine
James J RivielloUniversity of Texas Medical School, Boston Children's Hospital, Harvard Medical School, Columbia University School of Medicine, Kanagawa Children's Medical Center, Jichi Medical School, Washington State University, Baylor College of Medicine
Wendy K ChungUniversity of Texas Medical School, Boston Children's Hospital, Harvard Medical School, Columbia University School of Medicine, Kanagawa Children's Medical Center, Jichi Medical School, Washington State University, Baylor College of Medicine
Wendy K ChungUniversity of Texas Medical School, Boston Children's Hospital, Harvard Medical School, Columbia University School of Medicine, Kanagawa Children's Medical Center, Jichi Medical School, Washington State University, Baylor College of Medicine
Phillip L PearlUniversity of Texas Medical School, Boston Children's Hospital, Harvard Medical School, Columbia University School of Medicine, Kanagawa Children's Medical Center, Jichi Medical School, Washington State University, Baylor College of Medicine
  • 1 - 5

Datasets

Release 1.2